Currency converter
^
News Feed
News Search Topics
ОК
Use filter
You can filter your feed,
by choosing only interesting
sections.
Loading

Regulator urges simplified access of medicines registered in US, EU to Russia

October 29, 2015, 13:50 UTC+3 MOSCOW
In the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program
1 pages in this article
© Artyom Geodakyan/TASS

MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.

"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.

Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.

"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.

Show more
In other media
Реклама
Реклама